Related Experiment Video

Updated: Aug 9, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

p53 is mutated in a subset of advanced-stage prostate cancers

R Bookstein1, D MacGrogan, S G Hilsenbeck

  • 1Department of Molecular Biology, Canji, Inc., San Diego, California 92121.

Cancer Research
|July 15, 1993
PubMed

Insights

p53 gene mutations are uncommon in early prostate cancer but increase with advanced stages. These mutations may play a role in the progression of some prostate cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • p53 tumor suppressor gene inactivation is crucial in many human cancers.
  • Mutated p53 proteins often exhibit abnormal stability and nuclear accumulation.
  • Prostate cancer's p53 mutation landscape requires further investigation.

Purpose of the Study:

  • To determine the frequency, type, and clinical significance of p53 mutations in prostate cancer.
  • To assess the correlation between p53 accumulation and prostate cancer stage.
  • To identify specific p53 mutation patterns in prostate tumors.

Main Methods:

  • Immunohistochemistry (IHC) using anti-p53 antibodies on 150 prostate tumor samples.
  • Polymerase chain reaction (PCR), single-strand conformational polymorphism (SSCP), and direct sequencing for mutation analysis.
  • Statistical analysis, including Fisher's exact test, to evaluate correlations.

Main Results:

  • Abnormal nuclear p53 accumulation (IHC+) was detected in 12.7% of tumors.
  • p53 accumulation strongly correlated with advanced disease stage (III-IV vs. 0-II).
  • Mutations, primarily missense, were identified in 9 of 14 IHC+ cases, often at CpG sites, and absent in IHC- cases.

Conclusions:

  • Mutated p53 alleles are infrequent in early prostate cancer.
  • p53 mutations are present in 20-25% of advanced prostate cancers.
  • p53 mutation likely contributes to the progression of a subset of prostate cancers.

More Related Videos

Purification of Ubiquitinated p53 Proteins from Mammalian Cells10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...